Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group A β-hemolytic streptococci: An international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years

Clinical Therapeutics

Volumn 28, Issue 1, 2006, Pages 99-109

  Mahakit, Prasit ^a   Gil Vicente, José ^b   Igbal Butt, D ^c   Angeli, German ^d   Bansal, Sanjay ^e   Zambrano, David ^f,g  

^a Army Hospital   (Thailand)

^b Jose R Reyes Memorial Center   (Philippines)

^c JINNAH HOSPITAL   (Pakistan)

^d Hospital Luis Ortega   (Venezuela)

^e Bhandari Hospital   (India)

^f Pharmacia and Upjohn   (Hong Kong)

^g NONE

Author keywords

Acute recurrent pharyngotonsillitis; Amoxicillin clavulanic acid; Antibiotics; Clindamycin; Group A hemolytic streptococci

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CLINDAMYCIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; ERADICATION THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL SYSTEM MALFORMATION; NEUROLOGIC DISEASE; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SKIN DISEASE; STREPTOCOCCUS GROUP A; TONSILLITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CLAVULANIC ACID; CLINDAMYCIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHARYNGITIS; PROSPECTIVE STUDIES; RECURRENCE; SINGLE-BLIND METHOD; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TONSILLITIS; TREATMENT OUTCOME;

EID: 32844475316     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.01.006     Document Type: Article

References (58)

1. Rotta J., and Tikhomirov E. Streptococcal diseases worldwide: Present status and prospects Bull World Health Organ 65 1987 769 777
2. Denny F.W. Current management of streptococcal pharyngitis J Fam Pract 35 1992 619 620
3. Baker A.S., Behlau I., and Tierney M.R. Infections of the pharynx, larynx, epiglottis, trachea, and thyroid Gorbach S.L. Bartlett J.G. Blacklow N.R. Infectious Diseases 2nd ed. 1998 Saunders Philadelphia, Pa 540 548
4. Denny F.W. Effect of treatment on streptococcal pharyngitis: Is the issue really settled? Pediatr Infect Dis 4 1985 352 354
5. Hall C.B., and Breese B.B. Does penicillin make Johnny's strep throat better? Pediatr Infect Dis 3 1984 7 9
6. Krober M.S., Bass J.W., and Michels G.N. Streptococcal pharyngitis: Placebo-controlled double-blind evaluation of clinical response to penicillin therapy JAMA 253 1985 1271 1274
7. Nelson J.D. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis Pediatr Infect Dis 3 1984 10 13
8. Quinn R.W. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: The decline of rheumatic fever Rev Infect Dis 11 1989 928 953
9. Danjani A.S., Bisno A.L., and Chang K.J. Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association Circulation 78 1988 1082 1086
10. Breese B.B., Breese H.C., and Le C. Diagnosis of streptococcal pharyngitis Breese B.B. Breese Hall C. Beta-HemoOc Streptococcal Diseases 1978 Houghton Mifflin Boston, Mass 79 96
11. Tanz R.R., and Shulman S.T. Streptococcal pharyngitis. What's new Postgrad Med 84 1988 203 214
12. Wannamaker L.W. Diagnosis of pharyngitis: Clinical and epidemiologic features Shulman S.T. Pharyngitis: Management in an Era of Declining Rheumatic Fever 1984 Praeger New York, NY 33 46
13. Dillon H.C. Jr Streptococcal pharyngitis in the 1980s Pediatr Infect Dis J. 6 1987 123 130
14. Gastanaduy A.S., Kaplan E.L., and Huwe B.B. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis Lancet 2 1980 498 502
15. Smith T.D., Huskins W.C., Kim K.S., and Kaplan E.L. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the phar ynx after failureof penicillin therapy for group A streptococcal pharyngitis J Pediatr 110 1987 777 782
16. Stromberg A., Schwan A., and Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: A randomized controlled clinical trial with phenoxymethyl penicillinand cefadroxil Scand J Infect Dis 20 1998 37 46
17. Kaplan E.L., and Johnson D.R. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group a streptococci from children with acute pharyngitis Pediatrics 108 2001 1180 1186
18. Roos K., and Larsson R. Loracarbefversus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis Scand J Infect Dis 29 1997 141 145
19. Brook I. Failure of penicillin to eradicate group A betahemolytic streptococci tonsillitis: Causes and management J Otolaryngol 30 2001 324 329
20. Mitchelmore I.J., Reilly P.G., Hay A.J., and Tabagchali S. Tonsil surface and core cultures in recurrent tonsillitis: Prevalence of anaerobes and beta-lactamase producing organisms Eurj Clin Microbiol Infect Dis 13 1994 542 548
21. Brook I. Microbiology and management of respiratory tract infections J Infect Dis Antimicrob Agents 15 1998 139 150
22. Brook I., Yocum P., and Foote P.A. Jr Changes in the core tonsillar bacteriology of recurrent tonsillitis: 1997-1993 Clin Infect Dis. 21 1995 171 176
23. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection Rev Infect Dis 6 1984 601 607
24. Tuner K., and Nord C.E. Beta lactamase-producing microorganisms in recurrent tonsillitis Scand J Infect Dis Suppl 39 1983 83 85
25. Onrling A., Stjernquist-Desatnik A., Schalen C., and Kamme C. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment Scand J Infect Dis 26 1994 535 541
26. Maruyama S., Yoshioka H., and Fujita K. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan Am J Dis Child 133 1979 1143 1145
27. Rathore M.H., and Jenkins S.G. Group A beta-hemolytic Streptococcus: Issue of resistance Pediatr Infect Dis J 12 1993 354 355
28. Orrling A., Stjernquist-Desatnik A., and Schalen C. Clindamycin in recurrent group A streptococcal pharyngo tonsillitis - an alternative to tonsillectomy? Acta Otolaryngol. 117 1997 618 622
29. Randolph M.F., Redys J.J., and Hibbard E.W. Streptococcal pharyngitis. 3. Streptococcal recurrence rates follow ing therapy with penicillin or with clindamycin (7-cholorolincomycin) Del Med J 42 1970 87 92
30. Gallegos B., Rios A., Espidel A., and Reynal J.L. A double-blind, multicenter comparative study of two regimens ofclindamycin hydrochloride in the treatment of patients with acute streptococcaltonsillitis/pharyngitis Clin Ther 17 1995 613 621
31. Lundberg C., Heimdahl A., and Nord C.E. Clindamycin in the upper respiratory tract infections Scand J Infect Dis Suppl. 43 1984 50 55
32. Foote P.A. Jr, and Brook I. Penicillin and clindamycin therapy in recurrent tonsillitis. Effect of microbial flora Arch Otolaryngol Head Neck Surg. 115 1989 856 859
33. Boscarelli L., and Lo Bianco M.G. The use of clindamycin-2-palmitate and of erythromycin in infantile tonsillitis and pharyngotonsillitis [in Italian] Gazz Med Ital 139 1980 677 680
34. Neu H.C. Diagnosis and treatment: Drugs five years later. Amoxicillin Ann Intern Med 90 1979 356 360
35. Todd P.A., and Benfield P. Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use Drugs 39 1990 264 307
36. Facklam R.R. Specificity study of kits for detection of group A streptococci directly from throat swabs J Clin Microbiol. 25 1987 504 510
37. Pezzio M. Aerobic bacteriology Isenberg H.D. Essential Procedures for Clinical Microbiology 1998 American Society for Microbiology Press Washington, DC 122 126
38. Tuner K., and Nord C.E. Impact of phenoxymethylpenicillin and clindamycin on microflora in recurrent tonsillitis Ann Otol Rhinol Laryngol 94 1985 278 280
39. Agren K., Lundberg C., and Nord C.E. Effect of amoxycillin/clavulanic acid on the aerobic and anaerobic tonsillar microflora in the treatment of recurrent tonsillitis Scand J Infect Dis 22 1990 691 697
40. Hollander M., and Wolfe D.A. Nonparametric Statistical Methods 2nd ed. 1999 Wiley New York, NY
41. Tanz R.R., Poncher J.R., and Corydon K.E. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci J Pediatr 119 1991 123 128
42. Yokoi H., Murahashi K., and Yanagita N. Study of tissue concentration of clindamycin-2-phosphate and its clinical usefulness [in Japanese] Pract Otol. 78 1985 2891 2896
43. Martin du Pan R., and Harsch M. Treatment of recurrent tonsillitis in children with clindamycin: A multicen ter study [in French] Rev Med Suisse Romande 106 1986 967 970
44. Disanto A.R. Serum clindamycin levels study following multiple oral doses of Cleocin HCI given accord ing to a Q.6H. dosage regimen Protocol 313 Clinical Study 036 1972 Pharmacia & Upjohn Kalamazoo, Mich
45. Leigh D.A. Antibacterial activity and pharmacokinetics of clindamycin J Antimicrob Chemother 7 Suppl A 1981 3 9
46. Jungbluth G.L., Easterday P.L., and Borin M.T. Bioavailability evaluation of clindamycin following two multiple dose regimens of Cleocin HCI capsules Technical Report 7215/89/012 1989 Pharmacia & Upjohn Kalamazoo, Mich
47. Adam D., de Visser I., and Koeppe P. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination Antimicrob Agents Chemother 22 1982 353 357
48. Gálvez-Múgica M.A., Frías-Iniesta J., and Guerra P. Comparative bioavailability of two oral 875/125mg sachet formulations of amoxicillin/clavulanic acid in healthy volunteers Clin Drug Invest 18 1999 217 224
49. Calver A.D., Walsh N.S., Quinn P.F. Lower Respiratory Tract Infection Collaborative Study Group Dosing of amoxicillin/clavulanate given every 12 hours is as effective as dosing every 8 hours for treatment of lower respiratory tract infection Clin Infect Dis 24 1997 570 574
50. Catalano G.B., Serra A., and La Mantia I. Use of the combination of amoxicillin and clavulanic acid in infec tions of the ENT tract [in Italian] Riv Ital Otorinolaringol Audiol Foniatr 8 1988 359 365
51. Haczynski J., Chmielik M., and Bien S. A comparative study of cefaclor vs amoxicillin/clavulanate in pediat ric pharyngotonsillitis Med Sci Monit 9 2003 P129 P135
52. Taormina, Sicily. Abstract 39 Ottaviani A., Pagano A., and Sumbataro G. Study of efficacy of amoxicillin plus clavulanic acid in the treatment of ear, nose and throat infections Program and abstracts of the 6th Mediterranean Congress on Chemotherapy May 22-27, 1988
53. Rome, Italy Esposito S., Noviello S., D'Errico G., and Montanaro C. Amoxicillin/clavulanic acid in the treatment of ENT infec tions [in Italian] Presented at: 25th National Congress of the Italian Society for the Study of Infective and Parasitic Diseases October 10-14, 1989
54. Kaplan E.L., and Johnson D.R. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure J Pediatr 113 1988 400 403
55. Brook I., and Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to group A beta hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin, and clindamycin Clin Pediatr (Phila) 24 1985 331 336
56. Brook I. Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: A prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium J Antimicrob Chemother 24 1989 227 233
57. Silva J. Jr, and Zambrano D. Clindamycin: Toxicity and side effects Zambrano D. 2nd ed Clindamycin in the Treatment of Human Infections 1997 Pharmacia & Upjohn Kalamazoo, Mich 1 14
58. Croydon P. A worldwide survey of clinical experience with Augmentin J Drug Dev 2 Suppl 1 1989 67 69